Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases Income Tax Income Tax + AT Income Tax - 2020 (8) TMI AT This

  • Login
  • Cases Cited
  • Referred In
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2020 (8) TMI 173 - AT - Income Tax


Issues Involved:
1. Disallowance under Section 14A of the Income Tax Act.
2. Disallowance of expenditure related to the reduction of share capital.
3. Upward adjustment related to Advertisement, Marketing, and Sales Promotion (AMP) expenses.
4. Upward adjustment related to provision of research and development/testing services.

Issue-wise Analysis:

1. Disallowance under Section 14A:
The appellant contested the disallowance of ?66,18,230/- under Section 14A, arguing that no expenses were directly incurred for earning tax-free income. The AO computed the disallowance under Rule 8D, attributing ?37,03,813/- to interest expenses and ?29,14,417/- to administrative expenses. The Tribunal noted that the appellant's investments were made from its own surplus funds, referencing the Bombay High Court's decision in HDFC Bank Ltd., and deleted the disallowance of ?37,03,813/-. However, the disallowance of ?29,14,417/- for administrative expenses was upheld, as the appellant did not maintain separate books of accounts for exempt income.

2. Disallowance of Expenditure Related to Reduction of Share Capital:
The appellant incurred ?1,86,38,936/- for reducing the face value of its shares and claimed it as revenue expenditure. The AO treated it as capital expenditure. The Tribunal referenced the Gujarat High Court's decision in M/s Bayer Vapi Pvt. Ltd. and the Delhi High Court's decision in Selan Exploration Technology Ltd., distinguishing the case from Brooke Bond India Ltd., and concluded that the expenditure did not result in any enduring benefit or asset creation. Thus, the disallowance was deleted, allowing the expenditure as revenue in nature.

3. Upward Adjustment Related to AMP Expenses:
The AO made an upward adjustment of ?572,554,441/- for AMP expenses, alleging an arrangement between the appellant and its AE, CP USA. The Tribunal referenced its own decisions in the appellant's previous assessment years and the Bombay High Court's decision in Johnson & Johnson Ltd., which held that in the absence of an agreement obliging the appellant to incur AMP expenses on behalf of its AE, no international transaction could be presumed. Consequently, the upward adjustment was deleted.

4. Upward Adjustment Related to Provision of R&D/Testing Services:
The appellant contested the upward adjustment of ?86,59,200/- made by the TPO, who used single-year data and excluded certain comparables. The Tribunal directed the AO/TPO to re-examine the comparability of Dolphin Medical Services Ltd. and Medinova Diagnostic Services Ltd., and to exclude Alphageo (India) Ltd. from the set of comparables. The AO/TPO was also instructed to consider the appellant's contentions regarding risk and working capital adjustments. The matter was restored to the AO/TPO for fresh adjudication.

Additional Ground:
The appellant's additional ground regarding the revision of profit from the Baddi unit eligible for deduction under Section 80IC, consequent to the AMP expenditure adjustment, was deemed infructuous as the AMP adjustment was deleted.

Procedural Note:
The order was pronounced beyond the 90-day period due to the COVID-19 pandemic and subsequent lockdowns, invoking exceptions under Rule 34(5)(c) of the Income Tax Appellate Tribunal Rules, 1963.

Conclusion:
The appeal was partly allowed, with specific disallowances and adjustments being deleted or remanded for fresh consideration.

 

 

 

 

Quick Updates:Latest Updates